The global Biodefense market was valued at USD 15.4 Billion in 2022 and it is anticipated to grow up to USD 40.7 Billion by 2032 at a CAGR of 10.2% during the forecast period.
Biodefense can be defined as the activity of preparing for, responding to and countering the acts of bioterrorism. A bioterrorism attack involves the deliberate release of bacteria, viruses and other pathogens that can cause chronic illnesses to humans, animals, agriculture and the environment. Biodefense involves various medical measures that are undertaken to protect individuals against biological threats, such as administering vaccinations and medicinal drugs, along with conducting research and various public health procedures. Biodefense products are commonly effective against anthrax, smallpox, botulism, radiation/nuclear disasters and other such catastrophes.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10528
Market Trends and Drivers
Growing investments by government will augment the overall market progression
Growing investments by government in R&D that encourages pharmaceutical and biopharmaceutical companies to boost the production of vaccines will propel the biodefense market share. Increasing global biological threats has created need for funds to support the R&D activities. Government authorities’ stock large amounts of vaccines and bio-threat detection devices to combat against the deliberate virus attacks. For instance, as per the FDA FY 2023 budget, investment of USD 1.6 billion over five years has been allocated for biodefence vaccines and development of biodefense diagnostic devices. Therefore, growing investments in biodefense enables biopharmaceutical companies to manufacture technologically advanced biothreat detection devices that will significantly drive the industry outlook.
Major Players in the Global Biodefense Market
The key players in the market are XOMA corporation; Altimmune Inc. Emergent Biosolutions Inc.; Dynavax Technologies Corporation; SIGA Technologies; Elusys Therapeutics Inc.; Ichor Medical Systems; Dynport Vaccine Company; Cleveland Biolabs; Bavarian Nordic; Ology Bioservices; Alnylam Pharmaceuticals Inc., among others.
Speak to Analyst for more details: https://www.globalinsightservices.com/request-customization/GIS10528
COVID-19 Impact:
The outbreak of the COVID-19 pandemic has led to a significant increase in the demand for biodefense products, such as vaccines, therapeutics, and diagnostics, as healthcare professionals seek to protect themselves and others from the disease. The pandemic has also highlighted the importance of investing in strong biodefense infrastructure, which is expected to drive market growth over the forecast period.
Global Biodefense Market Segmentation
By Product
- Anthrax
- Botulism
- Smallpox
- Radiation/Nuclear
- Other Products
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10528
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/